-transparent.png){kind=logo}
The aim of the study was to investigate the pharmacokinetic modelling of Cefotaxime (CTX) and its main metabolite Desacetyl Cefotaxime (DCTX) which has a less antibacterial activity than the CTX. After intravenous administration of 1g of CTX to 26 patients, the plasma concentrations determined by HPLC showed that the pharmacokinetics of CTX and transformation to DCTX can be described with an open five-compartment model. The implications of this are discussed from the clinical point of view.
Related Publications
E Beyssac, and
J M Cardot, and
G Colnet, and
J Sirot, and
J M Aiache
September 1984,
The Journal of antimicrobial chemotherapy,
E Beyssac, and
J M Cardot, and
G Colnet, and
J Sirot, and
J M Aiache
April 1981,
Antimicrobial agents and chemotherapy,
E Beyssac, and
J M Cardot, and
G Colnet, and
J Sirot, and
J M Aiache
March 2007,
Clinical cancer research : an official journal of the American Association for Cancer Research,
E Beyssac, and
J M Cardot, and
G Colnet, and
J Sirot, and
J M Aiache
October 2008,
Infection,
E Beyssac, and
J M Cardot, and
G Colnet, and
J Sirot, and
J M Aiache
January 1984,
Chemotherapy,
E Beyssac, and
J M Cardot, and
G Colnet, and
J Sirot, and
J M Aiache
January 1986,
Therapeutic drug monitoring,
E Beyssac, and
J M Cardot, and
G Colnet, and
J Sirot, and
J M Aiache
January 1985,
Journal of pharmaceutical and biomedical analysis,
E Beyssac, and
J M Cardot, and
G Colnet, and
J Sirot, and
J M Aiache
April 1991,
Methods and findings in experimental and clinical pharmacology,
E Beyssac, and
J M Cardot, and
G Colnet, and
J Sirot, and
J M Aiache
June 1991,
The Journal of antimicrobial chemotherapy,
E Beyssac, and
J M Cardot, and
G Colnet, and
J Sirot, and
J M Aiache
January 1983,
Infection,
